...
首页> 外文期刊>Oncogene >PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612
【24h】

PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612

机译:PTBP3 剪接因子通过破坏 NEAT1 和 pre-miR-612 的剪接平衡来促进肝细胞癌

获取原文
获取原文并翻译 | 示例
           

摘要

Nuclear-enriched RNA-binding proteins (RBPs) are mainly involved in transcriptional regulation, which is a critical checkpoint to tune gene diversity and expression levels. We analyzed nuclear RBPs in human HCC tissues and matched normal control tissues. Based on the gene expression levels, PTBP3 was identified as top-ranked in the nuclei of HCC cells. HCC cell lines then were transfected with siRNAs or lentiviral vectors. PTBP3 promoted HCC cell proliferation and metastasis both in vitro and in vivo. RNA immunoprecipitation (RIP), fluorescence in situ hybridization (FISH) and qRT-PCR assays verified that PTBP3 protein recruited abundant lnc-NEAT1 splicing variants (NEAT1_1 and NEAT1_2) and pre-miR-612 (precursor of miR-612) in the nucleus. NEAT1_1, NEAT1_2 and miR-612 expression levels were determined by PTBP3. Correlational analyses revealed that PTBP3 was positively correlated with NEAT1, but it was inversely correlated with miR-612 in HCC. The P53/CCND1 and AKT2/EMT pathways were determined by NEAT1 and miR-612 respectively in HCC. The PTBP3(high) and NEAT1(high)/miR-612(low) patients had a shorter overall survival. Therefore, nuclear-enriched RBP, PTBP3, promotes HCC cell malignant growth and metastasis by regulating the balance of splicing variants (NEAT1_1, NEAT1_2 and miR-612) in HCC.
机译:核富集RNA结合蛋白(RBP)主要参与转录调控,转录调控是调控基因多样性和表达水平的关键检查点。我们分析了人HCC组织中的核RBPs,并匹配了正常对照组织。根据基因表达水平,PTBP3在HCC细胞核中被鉴定为顶级。然后用 siRNA 或慢病毒载体转染 HCC 细胞系。PTBP3在体外和体内促进HCC细胞增殖和转移。RNA 免疫沉淀 (RIP)、荧光原位杂交 (FISH) 和 qRT-PCR 检测证实 PTBP3 蛋白在细胞核中募集了丰富的 lnc-NEAT1 剪接变体(NEAT1_1 和 NEAT1_2)和 pre-miR-612(miR-612 的前体)。NEAT1_1、NEAT1_2 和 miR-612 表达水平由 PTBP3 测定。相关性分析显示,PTBP3与NEAT1呈正相关,但与HCC中的miR-612呈负相关。HCC 中 P53/CCND1 和 AKT2/EMT 通路分别由 NEAT1 和 miR-612 测定。PTBP3(高)和NEAT1(高)/miR-612(低)患者的总生存期较短。因此,富含核的 RBP PTBP3 通过调节 HCC 中剪接变体(NEAT1_1、NEAT1_2 和 miR-612)的平衡来促进 HCC 细胞恶性生长和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号